Instituto Ramón y Cajal de Investigación Sanitaria

Contacto
Logo IRYCIS

Información de contacto

Instituto Ramón y Cajal de Investigación Sanitaria
Emma González
emma.gonzalez@salud.madrid.org
Ctra.Colmenar Viejo Km 9,100, 28034
Madrid
Madrid
913369133
http://www.irycis.org
Áreas de actividad
  • A. Biotecnología Sanitaria
    • Campos de actividad
      • Biofármacos
      • Biomarcadores
      • Dispositivos médicos
      • Drug development
      • Drug discovery
      • Screening
      • Terapia génica
      • Vacunas
    • Áreas terapéuticas
      • Analgesia / Dolor
      • Dermatología
      • Desórdenes musculoesqueléticos
      • Enfermedades cardiovasculares y sistema circulatorio
      • Enfermedades genéticas y raras
      • Enfermedades infecciosas
      • Enfermedades inflamatorias
      • Ginecología y tocología
      • Inmunología
      • Odontología
      • Oftalmología y optometría
      • Oncología
      • Sangre y sistema linfático
      • Sistema digestivo y hepatología
      • Sistema genitourinario y riñón
      • Sistema nervioso central
      • Sistema respiratorio y pulmonar
      • Trastornos metabólicos / Endocrinología
  • D. Servicios
    • Servicios de I+D
      • Bioinformática
      • Genómica
      • Metabolómica
      • Proteómica
Comisiones
Comisión de salud
Comisión para el impulso del ecosistema

The Ramon y Cajal Institute for Biohealth Research (IRYCIS) is a large multidisciplinary organization which integrates scientific and clinical researchers, physicians, and other technical staff from the hospital.

The IRYCIS' aim is to join the knowledge, resources and initiatives of their members, leading to real advances for disease's prevention and treatment, and the improvement of diagnostics technologies.

Productos y servicios

The research groups of IRYCIS are classified in four major areas:

  • Neuroscience and Sense Organs
  • Microbiology, Immunology and Infection
  • Systemic Patology and Cancer
  • Clinical Epidemiology

The Institute led by its Innovation Unit (IU), aims to transfer the research and innovation beyond its walls, and to participate in an european open innovation context contributing to improve patient care and provide new solutions for unmet medical needs.

Áreas de interés para futuras colaboraciones

IRYCIS has a portfolio consisting of patents to out license, services to offer and research projects looking for industrial collaboration. The Institute also wants to open the door to new Horizon 2020 collaborations.

Biotech Sanitaria

Drugs National Companies
Producto / Servicio Tipo Área terapéutica Fase de desarrollo
New compound for the treatment of isquemical stroke Biodrugs/ Drugs Sistema nervioso central R&D
New aptamers for the treatment of stroke Biodrugs/ Drugs Sistema nervioso central P II
Research Platforms
Producto / Servicio Tipo Fase de desarrollo
miRNA platform Screening/Drug Discovery Clinical Validation
Diagnostics and Personalised Medicine
Producto / Servicio Tipo Área terapéutica Fase de desarrollo
Biomarkers to identify ocrelizumab good drug responders in patients with PP multiple sclerosis Biomarkers Inmunología, Sistema nervioso central Clinical Validation
Noverl biomarkers of acute kidney injury based on miRNAs Biomarkers, Diagnostic Sistema genitourinario y riñón Clinical Validation
Predictive biomarkers of response after neoadjuvant therapy in locally advanced rectal adenocarcinoma Biomarkers Oncología R&D
New aptamers for diagnosis of COVID19 Biomarkers, Diagnostic Inmunología R&D
New biomarkers to identify good responders to cis-platinum in lug cancer Biomarkers, Diagnostic Oncología Preclinical
miRNA 127 agents for use in the treatment of renal fibrosis Biomarkers, Diagnostic Sistema genitourinario y riñón Clinical Validation
New aptamers against HCV Biomarkers, Diagnostic Enfermedades infecciosas Preclinical
Diagnosis of osteoporosis with support of AI Diagnostic Desórdenes musculoesqueléticos R&D
Aptamers against MNK1 for the treatment of breast cancer Oncología Preclinical
Biomarkers to identify the response to OIT of children allergics to caw milk proteins Biomarkers, Diagnostic Inmunología Clinical Validation
Other Technologies
Producto / Servicio Área terapéutica Fase de desarrollo
Telemedicine platforms Oncología Preclinical